A new study finds men with a certain pattern of baldness by the age of 45 had a 39 percent increased risk of aggressive prostate cancer versus men with no baldness.
A cheap chemotherapy drug tested in St. Louis has been found to extend life for more than a year for men with whose prostate cancer has spread.
Up until now, ultrasound biopsies didn’t always target the cancer infected part of the prostate, leading to a hit-or-miss approach to the size or aggressiveness of the cancer.
Board Certified Oncologist Mark Schulz who is the Director of the Prostate Cancer Research Institute joins Jon this morning to talk about new aids in the fight against this devastating form of cancer. Composer Paul […]
The researchers argue that not only does the definition of cancer need to change, but in some cases, the word should be dropped from many common diagnoses.
The Siteman Cancer Center is now one of just five in the U.S. offering a new treatment for prostate cancer patients.
The American Urological Association now supports new guidelines which state routine screening is no longer recommended for men who are at average risk for the disease.
The typical patient taking Zytiga survived five months longer than the patient taking a fake pill, or placebo.
Washington University researchers, led by Dr. Graham Colditz, have developed a free iPad app that offers a quick assessment for six major diseases.
Intermittent hormonal therapy for certain men with minimal metastatic prostate cancer proved to be less effective than continuous therapy.